GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » C21 Investments Inc (OTCPK:CXXIF) » Definitions » EBITDA Margin %

C21 Investments (C21 Investments) EBITDA Margin % : 10.08% (As of Oct. 2023)


View and export this data going back to . Start your Free Trial

What is C21 Investments EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. C21 Investments's EBITDA for the three months ended in Oct. 2023 was $0.69 Mil. C21 Investments's Revenue for the three months ended in Oct. 2023 was $6.88 Mil. Therefore, C21 Investments's EBITDA margin for the quarter that ended in Oct. 2023 was 10.08%.


C21 Investments EBITDA Margin % Historical Data

The historical data trend for C21 Investments's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C21 Investments EBITDA Margin % Chart

C21 Investments Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -825.14 -51.87 17.30 62.82 24.17

C21 Investments Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.78 2.19 9.26 9.58 10.08

Competitive Comparison of C21 Investments's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, C21 Investments's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C21 Investments's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, C21 Investments's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where C21 Investments's EBITDA Margin % falls into.



C21 Investments EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

C21 Investments's EBITDA Margin % for the fiscal year that ended in Jan. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Jan. 2023 )/Revenue (A: Jan. 2023 )
=6.982/28.888
=24.17 %

C21 Investments's EBITDA Margin % for the quarter that ended in Oct. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Oct. 2023 )/Revenue (Q: Oct. 2023 )
=0.694/6.882
=10.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C21 Investments  (OTCPK:CXXIF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


C21 Investments EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of C21 Investments's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


C21 Investments (C21 Investments) Business Description

Traded in Other Exchanges
Address
601 West Cordova Street, Suite 280, Vancouver, BC, CAN, V6B 1G1
C21 Investments Inc is a vertically integrated cannabis company. It cultivates, processes, manufactures, and distributes cannabis and hemp-derived consumer products. C21's focus is to expand where the company can wholly own indoor or outdoor cultivation operations, extraction facilities, bakeries, branded products, and retail dispensaries with a large distribution network.

C21 Investments (C21 Investments) Headlines